Bernhard Dietzschold Thomas Jefferson University Paris, France May 2007 Dominance of a non-pathogenic over a pathogenic glycoprotein gene in rabies virus.

Slides:



Advertisements
Similar presentations
Points to Ponder What are three functions of DNA?
Advertisements

Pathogenesis and Control of Viral Infections Chapter 30.
Concepts Regarding Adenovirus based vaccine systems. By: Andrea Amalfitano D.O., Ph.D. Osteopathic Heritage Foundation Professor Dept of Microbiology and.
How Cell Work - Introduction of Molecular Biology.
20,000 GENES IN HUMAN GENOME; WHAT WOULD HAPPEN IF ALL THESE GENES WERE EXPRESSED IN EVERY CELL IN YOUR BODY? WHAT WOULD HAPPEN IF THEY WERE EXPRESSED.
Quasispecies Theory and the Behavior of RNA Viruses Sumeeta Singh, Steve Bowers, Greg Rice, Tom McCarty BINF /19/13.
Viruses.  What is a virus? Defined by their inability to replicate/multiply without utilizing a host cells reproductive mechanisms. Only contain ONE.
2 March, 2005 Chapter 12 Mutational dissection Normal gene Altered gene with altered phenotype mutagenesis.
Genetics & Gene Therapy (Ch.30) By: Mahmoud A. El-Hallak Mahmoud A. El-Hallak( ) Supervised by: Dr. Abdelraouf A. El manama Dr. Abdelraouf A. El.
Biotechnology and Recombinant DNA
Medical Technology Department, Faculty of Science, Islamic University-Gaza MB M ICRO B IOLOGY Dr. Abdelraouf A. Elmanama Ph. D Microbiology 2008 Chapter.
DNA Replication When a cell or organism reproduces, a complete set of genetic instructions must pass from one generation to the next.
Advanced Microbial Physiology
Viral Genetics and Replication SAMUEL AGUAZIM, M.D.
Chapter 19.1 & 19.3: Genetics of Viruses and Bacteria
Chapter 10 – DNA, RNA, and Protein Synthesis
PATHOGENESIS OF VIRAL DISEASES
Recombinant DNA. Scope Human Genome = 3x10 9 Average Gene = 3x10 4 (1/10 5 ) SNP Mutation (1/10 9 ) Process Cut DNA into pieces Insert DNA into vectors.
SCAVENGER HUNT 3 RD QUARTER. NUCLEOTIDE The rule: A-T, C-G.
Toll-Like Receptors in CNS Viral Infections Unclear role of TLRs in natural infections TLR3, -7, -8, -9 recognize viral nucleic acids. Localized intracellularly.
Biotechnology and Recombinant DNA
Seong-Eui Hong. Background
An Overview of the curriculum module available on
Microbial Biotechnology Philadelphia University
Using Comparative Genomics to Explore the Genetic Code of Influenza Sangeeta Venkatachalam.
DNA Chips Attach DNA to tiny spots on glass slides (i.e., chip). Hybridize fluorescently-labeled DNA probes to chip. Detect hybridization to different.
Copyright © 2010 Pearson Education, Inc. Lectures prepared by Christine L. Case Chapter 9 Biotechnology and Recombinant DNA.
Arabidopsis thaliana Response to Tobacco Rattle Virus Jessica Martin, Cory Zoetewey, and Lisa K. Johansen, Department of Biology University of Colorado.
Gene Therapy. Gene Therapy is a technique for correcting defective genes responsible for disease development Gene Therapy is a technique for correcting.
Scientific Reading and Writing in English discussion Shu-ying Wang, Ph.D. Dept. Microbiology and Immunology Tel: ext Fax:
REASSORTMENT OF INFLUENZA VIRUS
Chapter 12 Lecture Outline Molecular Techniques and Biotechnology.
Gene Therapy By: Chris Smith and Darran Prewitt. What is gene therapy? Why is it used? Gene therapy = Introduction of normal genes into cells that contain.
Characterizing and Classifying Viruses, Viroids, and Prions.
Project: Cellular microRNA profilings during the infections of the hepatitis C virus and the influenza A virus Yu Li Postdoc Fellow Katze Lab.
Viral Genetics and Replication SAMUEL AGUAZIM, M.D.
Virology 1.5-Genetics Some terminology from the last part of Chapter 3.
Chap 18 The Genetics of Viruses and Bacteria. Structure of Virus Approximately 20 nm in diameter Their genome can contain DNA or RNA. Enclosed by a.
Genetics & Gene Therapy Chapter 30 وسام عبد الرؤوف العايدي وسام عبد الرؤوف العايدي
Human cytomegalovirus (HCMV) is a member of the herpesvirus family. About 70-90% of the population is infected with HCMV. In healthy.
General, Organic, and Biological Chemistry Copyright © 2010 Pearson Education, Inc Viruses Chapter 21 Nucleic Acids and Protein Synthesis.
CD47 modulates the phagocytic clearance and replication of Plasmodium yoelii malaria parasite Rajdeep Banerjee 1, Sanjay Khandelwal 2, Yukiko Kozakai 1,
Copyright © 2010 Pearson Education, Inc. Lectures prepared by Christine L. Case Chapter 9 Biotechnology and Recombinant DNA.
March Notes: The Panama Puzzle Walter Reed: Major, US Army Medical Corps.
Viruses Lecture 16 Fall Viruses What is a virus? Are viruses alive? Read Discovery of Viruses pgs and Fig
Modern genetics.
Molecular Therapy - Methods & Clinical Development
Viral Genetics.
Immunology & Public Health
Figure 7.1 Polymerase chain reaction (PCR).
Agustina Setiawati, M.Sc., Apt
DNA VACCINES.
Relationship between Genotype and Phenotype
DNA Reflection After viewing and hearing your classmates presentations, and making you own, what do you specifically understand and what do you not specifically.
UNIT: DNA and RNA What is a mutation and how does it cause changes in organisms?  Mutations -changes in a single base pair in DNA=changes in the nucleotide.
UNIT: DNA and RNA What is a mutation and how does it cause changes in organisms?  Mutations Alternative alleles (traits) of many genes result from changes.
Biotechnology and Recombinant DNA
Relationship between Genotype and Phenotype
Sarah R. Gonzales-van Horn, Peter Sarnow  Cell Host & Microbe 
Volume 48, Issue 2, Pages (October 2012)
Reverse Vaccinology: Developing Vaccines in the Era of Genomics
Volume 22, Issue 3, Pages e5 (September 2017)
Volume 15, Issue 1, Pages (January 2014)
Volume 4, Issue 3, Pages (September 2008)
Engineering Viral Genomes: Adeno-Associated Vectors
Sarah R. Gonzales-van Horn, Peter Sarnow  Cell Host & Microbe 
Gene Protein Genome Proteome Genomics Proteomics.
Unit 4 - The Natural Environment and Species Survival
Volume 18, Issue 5, Pages (May 2010)
Hildegard Büning, Arun Srivastava 
Presentation transcript:

Bernhard Dietzschold Thomas Jefferson University Paris, France May 2007 Dominance of a non-pathogenic over a pathogenic glycoprotein gene in rabies virus

The RV G protein plays a major role in the pathogenesis of RV The RV G is not only the major antigen responsible for the induction of protective immunity, but is also a major contributor to the pathogenicity of the virus. The RV G is not only the major antigen responsible for the induction of protective immunity, but is also a major contributor to the pathogenicity of the virus. To abolish the pathogenicity, the recombinant RVs have been constructed to carry the G gene of SADB19 in which Arg333 is replaced by Glu333. To abolish the pathogenicity, the recombinant RVs have been constructed to carry the G gene of SADB19 in which Arg333 is replaced by Glu333. The Glu333 G protein, referred to as GAN, renders the virus non-pathogenic for adult mice after i.c. infection The Glu333 G protein, referred to as GAN, renders the virus non-pathogenic for adult mice after i.c. infection

An ARG ILE mutation in the RV G results in a loss of pathogenicity for adult mice An ARG ILE mutation in the RV G results in a loss of pathogenicity for adult mice

The non-pathogenic phenotype associated with GAN is not stable After several passages of SPBNGAN in mice, an Asn Lys mutation arose at position 194 of GAN resulting in GAK, which was associated with a reversion to the pathogenic phenotype. After several passages of SPBNGAN in mice, an Asn Lys mutation arose at position 194 of GAN resulting in GAK, which was associated with a reversion to the pathogenic phenotype.

Reversion to the pathogenic phenotype in GA variants after Virus Passage in suckling mice ND*** 9/10 (90%) SPBN** 4/10 (40%) 0/10 (10%) SPBNGA-Cyto-C SPBNGA-GA 1/10 (10%) 0/10 (10%) SPBNGA 10 th Mouse Passage 0 Passage Mortality* Virus Stock *Mice were infected i.c. with 10 4 FFU ** SPBN, leathal for adult mice, serves as a control ***ND = not done

Nucleotide Sequence Analysis of RV GA after the 5 th & 10 th Mouse Passage single-base change at nucleotide 639 of G: Asn 194 Lys 194 Asn 194 Lys 194 AAT AAG AAT AAG or or AAA AAA

Site-directed Mutagenesis of the GA Gene Asn 194 [N] Lys 194 [K] AAT AAG AAT AAG

Nonpathogenic G: GAN Nonpathogenic G: GAN –aa194 = Asn; aa333 = Glu Pathogenic G: GAK Pathogenic G: GAK –aa194 = Lys; aa 333= Glu

Mortality (A), clinical score (B), and body weight (C) of Swiss-Webster mice infected i.c. with different ratios of SPBNGAN and SPBNGAK

Effect of Asn Lys mutation on the pathogenicity of double G variants Because a RV vaccine candidate containing two GAN genes (SPBNGAN- GAN) exhibits increased immunogenicity in vivo as compared to the single GAN construct, we tested whether the presence of two GAN genes might also enhance the probability of reversion to pathogenicity Because a RV vaccine candidate containing two GAN genes (SPBNGAN- GAN) exhibits increased immunogenicity in vivo as compared to the single GAN construct, we tested whether the presence of two GAN genes might also enhance the probability of reversion to pathogenicity

Construction schematic of recombinant RVs containing one or two modified G genes encoding either an Asn (GAN) or a Lys (GAK) at position 194

Mortality (A), clinical score (B), and body weight (C) of Swiss-Webster mice infected i.c. with SPBNGAN-GAN, SPBNGAK-GAK, SPBNGAK-GAN, or SPBNGAN-GAK

Synthesis of genomic RV RNA (A) in the brain Synthesis of genomic RV RNA (A) in the brain and induction of RV VNA titers in the serum (B) of mice infected with double-G RV variants

Conclusions The pathogenicity of an RV containing a GAN and a GAK gene was strongly reduced as compared to that of an RV containing two GAK genes The pathogenicity of an RV containing a GAN and a GAK gene was strongly reduced as compared to that of an RV containing two GAK genes –This indicates that GAN is dominant in determining the pathogenicity phenotype of the RV.

Single-step virus growth curves (A) and mitochindrial respiration (B) in NA cells infected with double G RV variants

Transcription of viral mRNA (A) and viral genomic RNA (B) in NA cells infected with the single or double G recombinant RVs

Conclusions The pathogenicity of an RV correlates inversely with its replication rate in tissue culture The pathogenicity of an RV correlates inversely with its replication rate in tissue culture Virus production and viral RNA synthesis were markedly higher in SPBNGAN-, SPBNGAK-GAN- and SPBNGAN-GAK-infected neuroblastoma cells than in the SPBNGAK- and SPBNGAK-GAK-infected counterparts, Virus production and viral RNA synthesis were markedly higher in SPBNGAN-, SPBNGAK-GAN- and SPBNGAN-GAK-infected neuroblastoma cells than in the SPBNGAK- and SPBNGAK-GAK-infected counterparts, –This suggests control of GAN dominance at the level of viral RNA synthesis

Acknowledgements Milosz Faber and Jianwei Li Milosz Faber and Jianwei Li Thomas Jefferson University, Department of Microbiology & Immunology, Philadelphia, PA Marie-Luise Faber Marie-Luise Faber Molecular Targeting Technologies, Inc., West Chester, PA Matthias J. Schnell Matthias J. Schnell Thomas Jefferson University, Department of Microbiology and Immunology, Philadelphia, PA This work is supported by NIH Grants: This work is supported by NIH Grants: R01 AI R01 AI R01 AI R01 AI